Patients with advanced synovial sarcoma (SS)
Second-line chemotherapy regimens
Response rate
Second-line chemotherapy yields a poor response rate of 9.4% in advanced synovial sarcoma, highlighting an urgent need for novel therapeutic regimens.
Our exploratory study revealed that the response rate of second-line chemotherapy regimens for patients with SS was 9.4%. Therefore, there is an urgent need to develop more active therapeutic regimens for SSs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yuki Kojima
National Cancer Center Hospital East
Tatsunori Shimoi
National Cancer Center
Takuji Seo
Département Santé Animale
Oncology
National Cancer Center Hospital East
National Center for Global Health and Medicine
Building similarity graph...
Analyzing shared references across papers
Loading...
Kojima et al. (Sat,) studied this question.
synapsesocial.com/papers/69dcd6d5d111c0385b3595f0 — DOI: https://doi.org/10.1159/000524500
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: